Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by McKim, J. M.
Right arrow Articles by Meeks, R. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by McKim, J. M., Jr.
Right arrow Articles by Meeks, R. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1998 Oxford University Press

other

Evaluation of Octamethylcyclotetrasiloxane (D4) as an Inducer of Rat Hepatic Microsomal Cytochrome P450, UDP-Glucuronosyltransferase, and Epoxide Hydrolase: A 28-Day Inhalation Study

James M. McKim, Jr.*,1, Paul C. wilga*, Gary B. Kolesar*, Supratim Choudhuri*, Ajay Madan{dagger}, Leland W. Dochterman*, John G. Breen*, Andrew Parkinson{dagger}, Richard W. Mast{ddagger} and Robert G. Meeks*

*Dow Corning Corporation, Health and Environmental Sciences 2200 West Salzburg Road, Midland, Michigan 48686 {dagger}XenoTech LLC 3800 Cambridge, Kansas City, Kansas 66103 {ddagger}Everest Consulting Associates 15 N. Main Street, Cranbury, NJ 08512

Received May 21, 1997; accepted October 22, 1997

Repeated inhalation exposure to octamethylcyclotetrasiloxane (D4) produces a reversible and dose-related hepatomegaly and proliferation of hepatic endoplasmic reticulum in rats. However, the effects of D4 on the expression of cytochrome P450 enzymes have not been evaluated. In the present study, the time course for changes in hepatic microsomal cytochrome P450 enzyme expression following repeated inhalation exposure to D4 vapors was determined in male and female Fischer 344 rats. Animals were exposed to D4 vapor at concentrations of 70 and 700 ppm, via whole body inhalation for 6 h/day, 5 days/week for 4 weeks. Specified animals were euthanized on exposure days 3, 7, 14, 21, and 28. Microsomal fractions were prepared from fresh liver by differential centrifugation. Enzyme activity as well as immunoreactive protein levels of several cytochrome P450 enzymes (CYP), epoxide hy-drolase, and UDP-glucuronosyltransferase (UDPGT) were evaluated. The time course for enzyme induction was monitored by measuring 7-ethoxyresorufin O-deethylase (EROD) and 7-pentoxyresomfin O-depentylase (PROD) activities on days 3, 7, 14, 21, and 28. CYP1A1/2 activity, as determined by EROD activity, was increased approximately 2- to 3-fold over the exposure period. However, an examination of immunoreactive protein revealed no induction of CYP1A1 and a suppression of CYP1A2 in the 700 ppm D4 group. In comparison, CYP2B1/2 enzyme activity, as determined by PROD, was significantly increased as early as day 3 in both the 70 and 700 ppm D4 groups of male and female rats. Overall, PROD activity on day 28 was induced more than 10-fold in the 70 ppm D4 groups and more than 20-fold in the 700 ppm D4 groups. The increase in PROD activity was paralleled by a comparable increase in CYP2B1/2 immunoreactive protein. There was a modest (2- to 3-fold) increase in CYP3A1/2 activity and immunoreactive protein, as determined by 6ß-hydroxylation of testosterone and Western blot analysis. Expression of CYP enzymes was at or near maximum by day 14 and remained relatively constant throughout the exposure period. On day 28, epoxide hy-drolase activity and immunoreactive protein were induced (2- to 3-fold) in a dose-dependent manner. Only slight changes in the expression and activity of UDPGT were detected, and these did not appear to be dose related. Thus, repeated inhalation exposure to D4 induces CYP enzymes and epoxide hydrolase in a manner similar to that observed for phenobarbital (PB). Therefore, D4 can be described as a "PB-like" inducer of hepatic microsomal enzymes in the Fischer 344 rat.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
M. B. Reddy, M. E. Andersen, P. E. Morrow, I. D. Dobrev, S. Varaprath, K. P. Plotzke, and M. J. Utell
Physiological Modeling of Inhalation Kinetics of Octamethylcyclotetrasiloxane in Humans during Rest and Exercise
Toxicol. Sci., March 1, 2003; 72(1): 3 - 18.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Varaprath, J. M. McMahon, and K. P. Plotzke
Metabolites of Hexamethyldisiloxane and Decamethylcyclopentasiloxane in Fischer 344 Rat Urine---A Comparison of a Linear and a Cyclic Siloxane
Drug Metab. Dispos., February 1, 2003; 31(2): 206 - 214.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. M. McKim Jr., P. C. Wilga, W. J. Breslin, K. P. Plotzke, R. H. Gallavan, and R. G. Meeks
Potential Estrogenic and Antiestrogenic Activity of the Cyclic Siloxane Octamethylcyclotetrasiloxane (D4) and the Linear Siloxane Hexamethyldisiloxane (HMDS) in Immature Rats Using the Uterotrophic Assay
Toxicol. Sci., September 1, 2001; 63(1): 37 - 46.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. E. Andersen, R. Sarangapani, R. H. Reitz, R. H. Gallavan, I. D. Dobrev, and K. P. Plotzke
Physiological Modeling Reveals Novel Pharmacokinetic Behavior for Inhaled Octamethylcyclotetrasiloxane in Rats
Toxicol. Sci., April 1, 2001; 60(2): 214 - 231.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. P. Plotzke, S. D. Crofoot, E. S. Ferdinandi, J. G. Beattie, R. H. Reitz, D. A. McNett, and R. G. Meeks
Disposition of Radioactivity in Fischer 344 Rats after Single and Multiple Inhalation Exposure to [14C]Octamethylcyclotetrasiloxane ([14C]D4)
Drug Metab. Dispos., February 1, 2000; 28(2): 192 - 204.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
S. Varaprath, K. L. Salyers, K. P. Plotzke, and S. Nanavati
Identification of Metabolites of Octamethylcyclotetrasiloxane (D4) in Rat Urine
Drug Metab. Dispos., November 1, 1999; 27(11): 1267 - 1273.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.